| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical pharmacokinetic studies on factor VIII and factor IX – experiences from the Malmö centre
|
BJÖRKMAN, S.
|
|
2006
|
|
s4 |
p. 12-14
|
artikel
|
| 2 |
CME Information
|
|
|
2007
|
|
s4 |
p. iii-vi
|
artikel
|
| 3 |
Determination of minimal sampling time points for reliable pharmacokinetic evaluation of recombinant factor VIII – an exploratory population pharmacokinetic analysis in paediatric patients suffering from severe haemophilia
|
STASS, H.
|
|
2006
|
|
s4 |
p. 50-55
|
artikel
|
| 4 |
Drug dosing in children – special considerations
|
PENCHARZ, P. B.
|
|
2006
|
|
s4 |
p. 30-32
|
artikel
|
| 5 |
Factor VIII and thrombin generation assays: relevance to pharmacokinetic studies in haemophilia A
|
BARROWCLIFFE, T. W.
|
|
2006
|
|
s4 |
p. 23-29
|
artikel
|
| 6 |
Factor VIII pharmacokinetics: impact of low titer non-neutralizing inhibitors and use in determination of successful immune tolerance
|
DIMICHELE, D.
|
|
2006
|
|
s4 |
p. 56-60
|
artikel
|
| 7 |
Optimizing outcomes for patients with severe haemophilia A
|
PIPE, S. W.
|
|
2007
|
|
s4 |
p. 1-16
|
artikel
|
| 8 |
Participant Posttest and Evaluation
|
|
|
2007
|
|
s4 |
p. 17-20
|
artikel
|
| 9 |
Pharmacoeconomics of factor dosing in the haemophilia population
|
BERNTORP, E.
|
|
2006
|
|
s4 |
p. 70-73
|
artikel
|
| 10 |
Pharmacokinetics of factors IX, recombinant human activated factor VII and factor XIII
|
POON, M.-C.
|
|
2006
|
|
s4 |
p. 61-69
|
artikel
|
| 11 |
Pharmacokinetics of recombinant factor VIII (Kogenate-FS®) in children and causes of inter-patient pharmacokinetic variability
|
BARNES, C.
|
|
2006
|
|
s4 |
p. 40-49
|
artikel
|
| 12 |
Pharmacokinetic studies in patients with inherited bleeding disorders – challenges and relevance to clinical practice
|
Lee, C.A.
|
|
2006
|
|
s4 |
p. 1-2
|
artikel
|
| 13 |
Pharmacokinetic studies: international guidelines for the conduct and interpretation of such studies
|
MORFINI, M.
|
|
2006
|
|
s4 |
p. 6-11
|
artikel
|
| 14 |
Pharmacokinetic studies of coagulation factors: relevance of plasma and extracellular volume and body weight
|
KOMWILAISAK, P.
|
|
2006
|
|
s4 |
p. 33-39
|
artikel
|
| 15 |
Receptor-mediated clearance of factor VIII: implications for pharmacokinetic studies in individuals with haemophilia
|
SAENKO, E. L.
|
|
2006
|
|
s4 |
p. 15-22
|
artikel
|
| 16 |
State of the art international symposium on pharmacokinetics of factor concentrates in haemophilia: challenges and relevance to clinical practice. Summary statement
|
|
|
2006
|
|
s4 |
p. 3-5
|
artikel
|
Tijdschrift beschrijving